Pathology: mML - NA - all population; mML - NA - PDL1 positive;
mML - NA - all population | mML - NA - PDL1 positive | ||||
CheckMate 238, 2017 | IMMUNED (N vs P ; all population), 2020 | KEYNOTE 054 (all population), 2018 | KEYNOTE 054 (PDL1>1%), 2018 | ||
nivolumab alone | 2 | T1 | T1 | ||
pembrolizumab alone | 2 | T1 | T1 | ||
placebo | 0 | T0 | T0 | T0 | |
Ipilimumab (10 mg/kg) | 0 | T0 |